BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18458927)

  • 21. Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children.
    Milczuk HA
    Otolaryngol Head Neck Surg; 2003 Jun; 128(6):788-94. PubMed ID: 12825028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].
    Snoeck R; Wellens W; Desloovere C; Van Ranst M; Naesens L; De Clercq E; Feenstra L
    J Med Virol; 1998 Mar; 54(3):219-25. PubMed ID: 9515772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cidofovir: to use or not to use?
    Soma MA; Albert DM
    Curr Opin Otolaryngol Head Neck Surg; 2008 Feb; 16(1):86-90. PubMed ID: 18197029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis.
    Lott DG; Krakovitz PR
    Laryngoscope; 2009 Mar; 119(3):567-70. PubMed ID: 19235765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis.
    Gupta HT; Robinson RA; Murray RC; Karnell LH; Smith RJ; Hoffman HT
    Laryngoscope; 2010 Apr; 120(4):698-702. PubMed ID: 20205173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of local application of cidofovir on the control of recurrences in recurrent laryngeal papillomatosis.
    Pontes P; Avelino M; Pignatari S; Weckx LL
    Otolaryngol Head Neck Surg; 2006 Jul; 135(1):22-7. PubMed ID: 16815177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of dysplasia in juvenile-onset recurrent respiratory papillomatosis.
    Sajan JA; Kerschner JE; Merati AL; Osipov V; Szabo S; Blumin JH
    Arch Otolaryngol Head Neck Surg; 2010 Jan; 136(1):7-11. PubMed ID: 20083770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intralesional cidofovir for recurrent respiratory papillomatosis in children.
    Pransky SM; Magit AE; Kearns DB; Kang DR; Duncan NO
    Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1143-8. PubMed ID: 10522508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
    Wierzbicka M; Jackowska J; Bartochowska A; Józefiak A; Szyfter W; Kędzia W
    Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1305-11. PubMed ID: 21519834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis.
    Pransky SM; Brewster DF; Magit AE; Kearns DB
    Arch Otolaryngol Head Neck Surg; 2000 Oct; 126(10):1239-43. PubMed ID: 11031411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cidofovir activity in infantile recurrent respiratory papillomatosis].
    Palomar Asenjo V; Palomar García V; Soteras Ollé J; Ruiz Giner A
    Acta Otorrinolaringol Esp; 2005 Jan; 56(1):22-4. PubMed ID: 15747720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment results in adult-onset recurrent respiratory papillomatosis.
    Verguts MM; Genbrugge E; de Jong FI
    B-ENT; 2009; 5(3):137-41. PubMed ID: 19902848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intralesional cidofovir and surgical excision for laryngeal papillomatosis.
    Naiman AN; Ceruse P; Coulombeau B; Froehlich P
    Laryngoscope; 2003 Dec; 113(12):2174-81. PubMed ID: 14660923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In reference to Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis.
    Preuss SF; Quante G
    Laryngoscope; 2010 Mar; 120(3):650; author reply 651. PubMed ID: 20013845
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir--a prospective study.
    Dikkers FG
    Eur Arch Otorhinolaryngol; 2006 May; 263(5):440-3. PubMed ID: 16328406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
    Tjon Pian Gi RE; Ilmarinen T; van den Heuvel ER; Aaltonen LM; Andersen J; Brunings JW; Chirila M; Dietz A; Ferran Vilà F; Friedrich G; de Gier HH; Golusinski W; Graupp M; Hantzakos A; Horcasitas R; Jackowska J; Koelmel JC; Lawson G; Lindner F; Remacle M; Sittel C; Weichbold V; Wierzbicka M; Dikkers FG
    Eur Arch Otorhinolaryngol; 2013 May; 270(5):1679-87. PubMed ID: 23377227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Local application of cidofovir as adjuvant therapy in recurrent laryngeal papillomatosis in children].
    Pontes P; Weckx LL; Pignatari SS; Fujita RR; Avelino MA; Sato J
    Rev Assoc Med Bras (1992); 2009; 55(5):581-6. PubMed ID: 19918660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children.
    Akst LM; Lee W; Discolo C; Knott D; Younes A; Koltai PJ
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):841-6. PubMed ID: 12925342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
    Donne AJ; Rothera MP; Homer JJ
    Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal bridge and pitting of the true vocal fold: an unusual complication of cidofovir injection.
    Man LX; Statham MM; Rosen CA
    Ann Otol Rhinol Laryngol; 2010 Apr; 119(4):236-8. PubMed ID: 20433022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.